Miriam Rossi

Dr. Miriam Rossi

Vassar College
orcid

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Carbohydrate Research
Verified
Journal Article
Closed access
DLDavid Leal
David Leal
BMBetty Matsuhiro
Betty Matsuhiro
Miriam RossiMiriam Rossi
Miriam Rossi
FCFrancesco Caruso
Francesco Caruso

20 January 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Francesco CarusoFrancesco Caruso
Francesco Caruso
Miriam RossiMiriam Rossi
Miriam Rossi
ABAidan Benson
Aidan Benson
COCristian Opazo
Cristian Opazo
DFDaniel Freedman
Daniel Freedman
Claudio PettinariClaudio Pettinari
Claudio Pettinari

1 March 1985 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
Miriam RossiMiriam Rossi
Miriam Rossi
JGJenny P. Glusker
Jenny P. Glusker
LRLucio Randaccio
Lucio Randaccio
MSMichael F. Summers
Michael F. Summers
PTPaul J. Toscano
Paul J. Toscano
LMLuigi G. Marzilli
Luigi G. Marzilli

2 November 2004 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
FCFrancesco Caruso
Francesco Caruso
JTJoseph Tanski
Joseph Tanski
AVAdriel Villegas-Estrada
Adriel Villegas-Estrada
Miriam RossiMiriam Rossi
Miriam Rossi

1 January 2004 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
FCFrancesco Caruso
Francesco Caruso
Miriam RossiMiriam Rossi
Miriam Rossi
Most anticancer titanium compounds act against tumors in the gastrointestinal tract. Activity towards breast, lung and skin (melanoma) cancers is shown by some as well. Among their appealing properties is that they do not show common side effects of widely used cytostatic agents such as emesis, alopecia or bone marrow impairment. These features make titanium compounds interesting for combined therapy and further study. This review focuses on two drugs that reached clinical trials, namely, titanocene dichloride and budotitane. We try to integrate the biological fate of the related Ti-cyclopentadienyl and Ti-β-diketonato families of drugs, delineating the structure-activity relationship. We also discuss novel related species with increased solubility for improved drug delivery and some potentially useful polynuclear compounds.

1 March 1986 in Bioorganic Chemistry
Verified
Journal Article
Closed access
Miriam RossiMiriam Rossi
Miriam Rossi
LRLori F. Rickles
Lori F. Rickles
WHWendy A. Halpin
Wendy A. Halpin